Literature DB >> 20185331

Secretion profile of human bone marrow stromal cells: donor variability and response to inflammatory stimuli.

Victoria Zhukareva1, Maria Obrocka, John D Houle, Itzhak Fischer, Birgit Neuhuber.   

Abstract

Mesenchymal stem cells (MSC) derived from bone marrow are ideal transplants for a variety of CNS disorders and appear to support recovery after injury by secreting therapeutic factors. There is considerable variability in the secretion profile of MSC derived from different donors and it is known that MSC secretion changes in response to inflammatory stimuli, but no comprehensive analysis has been performed to address these issues. Here we show that MSC from seven donors secrete chemokines and cytokines in variable ranges, with some factors showing high variability. Treatment of cultured MSC with pro-inflammatory cytokines or tissue extracts from injured spinal cord resulted in up-regulation of selected cytokines, whereas treatment with an anti-inflammatory cytokine had little effect, indicating that the secretion profile is tightly regulated by environmental challenges. Patterns of up-regulated cytokines were similar in MSC from different donors suggesting a comparable response to inflammatory stimuli. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20185331     DOI: 10.1016/j.cyto.2010.01.004

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  36 in total

1.  Donor variability among anti-inflammatory pre-activated mesenchymal stromal cells.

Authors:  Andrea Gray; Rene S Schloss; Martin Yarmush
Journal:  Technology (Singap World Sci)       Date:  2016-09

2.  Engineering cells with intracellular agent-loaded microparticles to control cell phenotype.

Authors:  James A Ankrum; Oscar R Miranda; Kelvin S Ng; Debanjan Sarkar; Chenjie Xu; Jeffrey M Karp
Journal:  Nat Protoc       Date:  2014-01-09       Impact factor: 13.491

3.  αSMA Expression in Large Colonies of Colony-Forming Units-Fibroblast as an Early Predictor of Bone Marrow MSC Expandability.

Authors:  Irina Aizman; William S Holland; Cher Yang; Damien Bates
Journal:  Cell Med       Date:  2016-10-06

4.  Effects of mesenchymal stem cell and fibroblast coating on immunogenic potential of prosthetic meshes in vitro.

Authors:  Yue Gao; David M Krpata; Cory N Criss; Lijia Liu; Natasza Posielski; Michael J Rosen; Yuri W Novitsky
Journal:  Surg Endosc       Date:  2014-06-28       Impact factor: 4.584

5.  Immunosuppression of allogenic mesenchymal stem cells transplantation after spinal cord injury improves graft survival and beneficial outcomes.

Authors:  Abel Torres-Espín; Elena Redondo-Castro; Joaquim Hernandez; Xavier Navarro
Journal:  J Neurotrauma       Date:  2015-01-22       Impact factor: 5.269

Review 6.  Mesenchymal stem cells: immune evasive, not immune privileged.

Authors:  James A Ankrum; Joon Faii Ong; Jeffrey M Karp
Journal:  Nat Biotechnol       Date:  2014-02-23       Impact factor: 54.908

Review 7.  Acceleration of Wound Healing by Multiple Growth Factors and Cytokines Secreted from Multipotential Stromal Cells/Mesenchymal Stem Cells.

Authors:  Kenichi Tamama; Svetoslava S Kerpedjieva
Journal:  Adv Wound Care (New Rochelle)       Date:  2012-08       Impact factor: 4.730

8.  Prostaglandin E2 Produced by Alginate-Encapsulated Mesenchymal Stromal Cells Modulates the Astrocyte Inflammatory Response.

Authors:  Elizabeth C Stucky; Joshua Erndt-Marino; Rene S Schloss; Martin L Yarmush; David I Shreiber
Journal:  Nano Life       Date:  2017-06

9.  Regenerative Potential and Inflammation-Induced Secretion Profile of Human Adipose-Derived Stromal Vascular Cells Are Influenced by Donor Variability and Prior Breast Cancer Diagnosis.

Authors:  Adrienne M Parsons; Deborah M Ciombor; Paul Y Liu; Eric M Darling
Journal:  Stem Cell Rev Rep       Date:  2018-08       Impact factor: 5.739

10.  Multipotent stromal cells skew monocytes towards an anti-inflammatory interleukin-10-producing phenotype by production of interleukin-6.

Authors:  Sara M Melief; Sacha B Geutskens; Willem E Fibbe; Helene Roelofs
Journal:  Haematologica       Date:  2013-01-24       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.